Ameritas Investment Company’s Medifast MED Stock Holding History

Ameritas Investment Company’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2	Closed	-$426	–	1516
2021 Q1	$426	Buy	+2	New	+$479	﹤0.01%	2198

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameritas Investment Company's MED Position: Q2 2021 in Review

Ameritas Investment Company sold out of Medifast (MED) in Q2 2021, closing a stake of 2 shares — an estimated $426 sold.

Ameritas Investment Company first reported a position in MED in Q1 2021 and held it in 1 quarter. The position peaked at $426 in Q1 2021. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

Ameritas Investment Company reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 2 Medifast shares in Q2 2021, an estimated $426.
Ameritas Investment Company first reported a position in Medifast in Q1 2021 and held it in 1 quarter.
Ameritas Investment Company's Medifast position peaked at $426 in Q1 2021.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.